CNS vs VCTR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CNS

34.6
AI Score
VS
VCTR Wins

VCTR

40.7
AI Score

Investment Advisor Scores

CNS

35score
Recommendation
AVOID NEW MONEY

VCTR

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS VCTR Winner
Forward P/E 18.1159 11.2613 VCTR
PEG Ratio 1.3225 0 Tie
Revenue Growth 11.1% 9.8% CNS
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 34.6/100 40.7/100 VCTR
Profit Margin 28.2% 28.6% VCTR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD VCTR

Relative Price Performance (Last 90 Days)

CNS 1M: +5.6% · 3M: -15.1% VCTR 1M: +14.8% · 3M: +6.4%

Current Technical Phase

CNS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50

RSI (14): 49.8 · Price: $72.72

VCTR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.2 · Price: $125.74

Fundamentals Snapshot

Metric CNS VCTR
Market Cap — —
Forward P/E 19.6 14.0
Trailing P/E 22.7 23.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.3% 0.5%
EPS 3.25 5.46
Dividend Yield 0.04% 0.02%

Frequently Asked Questions

Based on our detailed analysis, VCTR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.